Cite
HARVARD Citation
Hofving, T. et al. (2019). 177Lu-octreotate therapy for neuroendocrine tumours is enhanced by Hsp90 inhibition. Endocrine-related cancer. 26 (4), pp. 437-449. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hofving, T. et al. (2019). 177Lu-octreotate therapy for neuroendocrine tumours is enhanced by Hsp90 inhibition. Endocrine-related cancer. 26 (4), pp. 437-449. [Online].